Neurosurgery News and Research

RSS

Clinical trial to examine use of biomarkers to advance treatment of malignant gliomas launched

The Brain Tumor Unit at the Moores UCSD Cancer Center at the University of California, San Diego in La Jolla, is launching a clinical trial that will examine the use of biomarkers to advance the treatment of malignant gliomas, brain tumors that start in the brain or spinal cord tissue. Annually, about 17,000 Americans are diagnosed with gliomas, which are difficult to treat and often fatal.

16 Jun 2010

New data shows Ohio children with special health care needs have inadequate insurance coverage

A third of Ohio children with special health care needs have unstable or inadequate insurance coverage despite the fact that they may qualify for government health programs, according to a new data analysis by the Child Policy Research Center at Cincinnati Children's Hospital Medical Center.

16 Jun 2010

Elekta exercises share repurchase authorization

The Board of Directors of Elekta AB has decided to utilize the authorization received from the Annual General Meeting to repurchase shares in the company.

From Elekta 16 Jun 2010

Diversity publication recognizes UH as a leader among health care institutions

DiversityInc, a leading publication on diversity and business, has recognized University Hospitals as a leader among health care institutions in its first ever Top Hospital Systems listing.

15 Jun 2010

Synergetics third-quarter 2010 sales increase 5.3% to $13.9 million

Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative microsurgical instruments for ophthalmic and neurosurgical applications, today announced its results for the third quarter and nine months ended April 30, 2010.

15 Jun 2010

SCS may be able to modulate PD symptoms: Study

A new study from Rhode Island Hospital indicates that spinal cord stimulation may be able to modulate Parkinson's disease symptoms. The lead author will present the findings at the 2010 American Society for Stereotactical and Functional Neurosurgery Biennial Meeting, June 14-16 in New York City.

15 Jun 2010

Aesculap receives FDA clearance for SterilContainer product line for use in STERIS V-PRO systems

Aesculap, Inc. is pleased to announce that the SterilContainer S product line has been cleared by the United States Food and Drug Administration (FDA), (510(k) number, K093649) for use in the STERIS Corporation's V-PRO 1 and V-PRO 1 Plus Low Temperature Sterilization Systems.

14 Jun 2010

ARBs increase risk of cancer: Study

University Hospitals Case Medical Center cardiologists have uncovered new research showing an increased risk of cancer with a group of blood pressure medications known as angiotensin-receptor blockers (ARBs).

14 Jun 2010

Study: Children with idiopathic onset epilepsy have high remission rate

A study conducted by researchers in The Netherlands confirmed that children with idiopathic new-onset epilepsy have a significantly higher rate of remission than those with remote symptomatic epilepsy.

14 Jun 2010

Seminar on pros and cons of robotic surgery

Robotic surgery - is it truly an advance for modern medicine, or just a product of slick consumer advertising campaigns and targeted marketing to physicians?

11 Jun 2010

Researchers to provide real-time analyses on potential disease threats during World Cup

Two Canadian researchers will be keeping a close eye on what hundreds of thousands of soccer fans take to the World Cup in South Africa _ and what they potentially bring home.

11 Jun 2010

Integra LifeSciences announces over 800 implantations of Vu a-POD fusion device

Integra LifeSciences announced today a major milestone in the commercialization of the Vu a-POD™ anterior lumbar intervertebral body fusion (ALIF) device. Launched in the U.S. in early 2009, the Vu a-Pod™ fusion device has now been implanted in over 800 patients in the U.S.

8 Jun 2010

Top 10 tips to avoid medical mistakes

In this new original and eye-opening book, THE NOT SO PATIENT ADVOCATE: How To Get The Healthcare You Need Without Fear Or Frustration, readers walk through the seemingly forbidden or secretive door to the mystifying and occasionally infuriating maze that is today's healthcare machine. The author shares candid facts about what actually goes on where healthcare interaction occurs.

8 Jun 2010

Elekta Neuromag TRIUX system unveiled at Organization of Human Brain Mapping's Annual Meeting

At the Organization of Human Brain Mapping's 16th Annual Meeting (Barcelona, Spain, June 6-10), Elekta unveiled its next generation magnetoencephalography system, Elekta Neuromag TRIUX. A platform that addresses key requirements critical for monitoring normal and abnormal brain activity, Elekta Neuromag TRIUX was designed to operate in virtually any clinical environment – an advance welcomed by the growing number of Elekta Neuromag clinical and research facilities worldwide.

From Elekta 7 Jun 2010

Positive phase III clinical trial data of NovoCure's NovoTTF device for recurrent GBM presented at ASCO

Data from the first phase III clinical trial of NovoCure's NovoTTF device for treatment of patients with recurrent glioblastoma (GBM) were presented today as a late breaking abstract during the Neuro-Oncology session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Study results show that NovoTTF, a novel, non-invasive, portable medical device, may be as or more effective than the best available chemotherapies for GBM, but without the toxicity usually associated with cytotoxic or targeted treatments.

7 Jun 2010

NewYork-Presbyterian Hospital recognized as leader in all 10 clinical specialties

NewYork-Presbyterian Hospital is the only tri-state-area hospital listed on the 2010 U.S.News & World Report "America's Best Children's Hospitals" "Honor Roll" and one of only eight children's hospitals in the nation to be ranked in all 10 clinical specialties. NewYork-Presbyterian provides children's health services at two major centers: NewYork-Presbyterian/Morgan Stanley Children's Hospital and the Phyllis and David Komansky Center for Children's Health.

5 Jun 2010

Medtronic DBS Therapy improves motor function in patients with advanced Parkinson's disease: Study

In the largest, randomized, controlled study of deep brain stimulation for Parkinson's disease, Medtronic DBS Therapy was shown to improve motor function for up to two years in patients with advanced Parkinson's disease, showing equally strong efficacy for the two most common surgical targets used for the therapy.

3 Jun 2010

Synergetics reports preliminary results for third-quarter fiscal 2010

Synergetics USA, Inc. today announced its preliminary results for the third fiscal quarter ended April 30, 2010 related to the allocation of proceeds from the settlement, license and supply agreement with Alcon Laboratories, Inc. and the expected gain from the sale of the Omni® product line to Stryker Corporation.

2 Jun 2010

GMC to participate in ProTECT III study of progesterone for emergency treatment of TBI

Geisinger Medical Center will participate in ProTECT III, a groundbreaking National Institute of Health -sponsored research study for the emergency treatment of traumatic brain injuries using the hormone progesterone.

2 Jun 2010

Mannitol improves effectiveness of HUCBs in neonatal rat models of cerebral palsy

The sugar-alcohol compound mannitol improved the therapeutic effectiveness of human umbilical cord blood cells injected into neonatal rat models of cerebral palsy, reports a new international study led by the University of South Florida. The mannitol opened the blood-brain barrier by temporarily shrinking the tight endothelial cells that make up the barrier.

2 Jun 2010

Neurosurgery News and Research

Clinical trial to examine use of biomarkers to advance treatment of malignant gliomas launched

New data shows Ohio children with special health care needs have inadequate insurance coverage

Elekta exercises share repurchase authorization

Diversity publication recognizes UH as a leader among health care institutions

Synergetics third-quarter 2010 sales increase 5.3% to $13.9 million

SCS may be able to modulate PD symptoms: Study

Aesculap receives FDA clearance for SterilContainer product line for use in STERIS V-PRO systems

ARBs increase risk of cancer: Study

Study: Children with idiopathic onset epilepsy have high remission rate

Seminar on pros and cons of robotic surgery

Researchers to provide real-time analyses on potential disease threats during World Cup

Integra LifeSciences announces over 800 implantations of Vu a-POD fusion device

Top 10 tips to avoid medical mistakes

Elekta Neuromag TRIUX system unveiled at Organization of Human Brain Mapping's Annual Meeting

Positive phase III clinical trial data of NovoCure's NovoTTF device for recurrent GBM presented at ASCO

NewYork-Presbyterian Hospital recognized as leader in all 10 clinical specialties

Medtronic DBS Therapy improves motor function in patients with advanced Parkinson's disease: Study

Synergetics reports preliminary results for third-quarter fiscal 2010

GMC to participate in ProTECT III study of progesterone for emergency treatment of TBI

Mannitol improves effectiveness of HUCBs in neonatal rat models of cerebral palsy

Neuroscience - Third Edition eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News